Pcv83 - Key Model Parameters and Methodologies Used in Cost-Effectiveness Analysis Evaluating Treatments for Secondary Prevention of Major Adverse Cardiovascular Events (Mace) in Patients With a Prior Myocardial Infarction (Mi) or Acute Coronary Syndrome (Acs)
Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.629
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV